Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy
Inherited retinal diseases (IRDs) are a leading cause of blindness in industrialized countries, and gene therapy is quickly becoming a viable option to treat this group of diseases. Gene replacement using a viral vector has been successfully applied and advanced to commercial use for a rare group of...
Saved in:
Main Authors: | Duohao Ren (Author), Sylvain Fisson (Author), Deniz Dalkara (Author), Divya Ail (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Viral gene delivery vectors: the next generation medicines for immune-related diseases
by: Peter De Haan, et al.
Published: (2021) -
The future of non-viral gene delivery for the treatment of inherited retinal diseases
by: Jyoti Sharma, et al.
Published: (2022) -
In vivo genome editing for hemophilia B therapy by the combination of rebalancing and therapeutic gene knockin using a viral and non-viral vector
by: Jeong Hyeon Lee, et al.
Published: (2023) -
Transferrin Non-Viral Gene Therapy for Treatment of Retinal Degeneration
by: Karine Bigot, et al.
Published: (2020) -
Viral vector‐based gene therapies in the clinic
by: Zongmin Zhao, et al.
Published: (2022)